New Study Conducted at Sheppard Pratt Finds Psilocybin-Assisted Therapy May Reduce Chronic Suicidal IdeationMorningStar·May 26 at 12:50 PMMNMD0.00%CMPS-4.00%
Trump Wants to Give Psychedelics Stocks a Boost. Can This Leading Company Deliver?Barchart Option·Apr 28 at 02:45 PMCMPS-4.00%ATAI+0.24%
FDA Moves To Fast-Track Psychedelic Therapies For Mental Healthrttnews·Apr 24 at 04:50 PMATAI+0.24%CYBN0.00%
Trump’s Rogan-inspired psychedelics order stokes cautious optimismThehill·Apr 22 at 10:05 PMSEEL0.00%SEELQ0.00%
Trump Order To Accelerate Treatments For Serious Mental Illnessrttnews·Apr 20 at 06:37 AMCMPS-4.00%MNMD0.00%
After Trump signed the executive order to expedite the treatment of severe mental illnesses, Psychedelic Pharmaceuticals shares roseAASTOCKS·Apr 20 at 06:23 AMDFTX-1.36%ATAI+0.24%
Trump: Accelerate access to research on psychedelic drugsWallstreetcn·Apr 18 at 08:14 AMGHRS+0.69%MNMD0.00%
Trump orders faster review of psychedelic drugs including ibogaineBusiness Standard·Apr 18 at 03:51 AMATAI+0.24%CMPS-4.00%
Cybin Inc. (NASDAQ:HELP) Given Average Recommendation of "Buy" by BrokeragesMarket Beat·Apr 13 at 09:39 AMCYBN0.00%HELP-1.11%
10:50 ETCNS Drug Developers Add Pharma Veterans as Sector Nears First FDA Decisionsprnewswire·Mar 9 at 09:52 AMXBI-1.41%BBH0.00%
Cybin’s Helus Pharma Posts Strong Phase 2 Data for HLP004 in Hard-to-Treat AnxietyTip Ranks·Mar 5 at 07:17 AMXBI-1.41%BBH0.00%
